Related Experiment Video
Updated: Jan 9, 2026

06:55
Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
Published on: December 5, 2015
14.0K
Provisional Versus Final Cause of Maternal Death on Autopsy: Exploring the Gaps
Sneha Debbarma1,2, Kusum Jashnani3, Lalita Patil3
1Department of Pathology, Tripura Santiniketan Medical College, Agartala, Tripura.
The American Journal of Forensic Medicine and Pathology
|December 3, 2025
Summary
Accurate maternal death determination is crucial. This study found significant discrepancies between provisional and final autopsy diagnoses, particularly in lung pathologies like ARDS, highlighting diagnostic challenges in maternal mortality reviews.
Area of Science:
- Pathology
- Forensic Medicine
- Obstetrics & Gynecology
Background:
- Accurate determination of maternal mortality cause is vital globally.
- Maternal death autopsies are typically pathology-based, excluding medicolegal cases.
- Clinical queries prompted this investigation into autopsy diagnosis discrepancies.
Purpose of the Study:
- To compare provisional (PCOD) and final (FCOD) causes of death in maternal autopsies.
- To analyze discrepancies and their impact on understanding maternal mortality.
- To identify common pathologies and organs involved in diagnostic discrepancies.
Main Methods:
- Retrospective analysis of 92 maternal death autopsies with PCOD/FCOD discrepancies over 6 years.
- Classification of discrepancies into major and minor categories.
- Assessment of common pathologies for diagnostic accuracy (true/false positives/negatives).
Main Results:
- The lung was the most frequent site of discrepancy (78% major), followed by brain, liver, kidney, and heart.
- Acute respiratory distress syndrome (ARDS) and bronchopneumonia were common causes of death with high discrepancy rates (75% major for ARDS).
- Misdiagnosis on gross examination, particularly for ARDS, contributed to discrepancies.
Conclusions:
- Significant discrepancies exist between provisional and final autopsy diagnoses in maternal deaths.
- Gross pathological limitations, especially with overlapping features, contribute to diagnostic challenges.
- Improving autopsy accuracy is essential for precise maternal mortality attribution and review.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Fetal Circulation
2.4K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.4K
Kaplan-Meier Approach
537
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
537

